Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease

Figure 1

Box plots showing PAI-1 antigen plasma levels between diabetic subjects plus the Metabolic Syndrome and the reference group. + = Mean; value; PAI-1 = plasminogen activator inhibitor type-1; T2DM = type 2 diabetes mellitus; MetS = the Metabolic Syndrome.